These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
683 related articles for article (PubMed ID: 28024568)
1. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells. Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991 [TBL] [Abstract][Full Text] [Related]
3. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells. Mosafer J; Mokhtarzadeh A Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods. Mosafer J; Teymouri M Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586 [TBL] [Abstract][Full Text] [Related]
5. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles. Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy. Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459 [TBL] [Abstract][Full Text] [Related]
7. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069 [TBL] [Abstract][Full Text] [Related]
9. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
10. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release]. Li JL; Zheng CL; Liu JP; Zhu JB Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702 [TBL] [Abstract][Full Text] [Related]
11. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of doxorubicin loaded polymeric nanoparticles using Box-Behnken design: ex-vivo stability and in-vitro activity. Shaikh MV; Kala M; Nivsarkar M Eur J Pharm Sci; 2017 Mar; 100():262-272. PubMed ID: 28126560 [TBL] [Abstract][Full Text] [Related]
13. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy. Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518 [TBL] [Abstract][Full Text] [Related]
14. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery. Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238 [TBL] [Abstract][Full Text] [Related]
15. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells. Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma. Zhang X; Zhao L; Zhai G; Ji J; Liu A Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143 [TBL] [Abstract][Full Text] [Related]
18. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Zhang Z; Huey Lee S; Feng SS Biomaterials; 2007 Apr; 28(10):1889-99. PubMed ID: 17197019 [TBL] [Abstract][Full Text] [Related]
19. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers. Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667 [TBL] [Abstract][Full Text] [Related]
20. Polymeric-gold nanohybrids for combined imaging and cancer therapy. Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]